February 2026 Congressional Memo

This briefing provides Members of the 119th Congress and congressional staff with a patient-centered overview of how the FY2026 budget will shape federal medical cannabis policy in the coming year. It includes an analysis of President Trump’s December Executive Order, the real-world implications of Schedule III classification, and a detailed examination of what a comprehensive national medical cannabis program would entail. For questions or additional information, please contact Americans for Safe Access at [email protected]

• Federal Medical Cannabis Update (page 1)
• Impact of FY2026 on Medical Cannabis Policy (page 2)
• Overview of Medical Cannabis Executive Order (page 12)
• Medical Cannabis & Cannabinoid Act (MCCA) (page 15)
• National Medical Cannabis Program Deep Dive (page 16)
• National Medical Cannabis Program Talking Points (page29)